Pharmaceutical Business review

Biolase names new CFO

Mr Mulder replaces interim CFO Frederick Capallo, who will continue to serve as corporate controller. Mulder will report directly to CEO Jake St Philip.

For the last two years, Mr Mulder served as the CFO and the COO of a private equity turn-around company. He started his career in accounting and consulting with Arthur Anderson, and has an MBA from Duke University’s Fuqua School of Business.

St Philip said: “David has the breadth of background and expertise that will make him a key part of the Biolase executive team. His corporate and international financial background and his experience working for companies with a global reach, will be critical as we grow in the US and abroad and as we continue to penetrate new global markets.”